ClinicalTrials.gg
Status unknownNCT06527105Updated Sep 25, 2024

Impact of Sleep Quality on Outcomes After Cardiac Surgery

An interventional study of Eye masks and ear plugs in Sleep, Atrial Fibrillation and Delirium, Postoperative, sponsored by Amrita Institute of Medical Sciences & Research Center. Status unknown at 1 site in India. Open to participants aged 18 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-09-25.

Sponsored by Amrita Institute of Medical Sciences & Research Center · Not applicable, Interventional, and Prevention

The sponsor has not verified this record recently (last verified Sep 2024), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Study summary

Sleep is a basic human need and is essential for good quality of life, good health. In fact, humans spend one third of their life time in sleeping or attempting to do so. However, sleep is not given due importance in intensive care unit (ICU)'s, although it is critical in healing process. Patient's usually get admitted to the hospital few days prior to the surgery, for complete evaluation, depending on the procedure planned. Hospital environment being, an entirely new place for inpatients, will invariably affect their sleep. Sleep deprivation is one of the major sources of anxiety and stress in all the patients during ICU stay. This means that most of patients are sleep deprived, by the time they are admitted to ICU.

The negative effects of sleep deprivation include postoperative brain dysfunction like inattention, restlessness, hallucinations, agitation, aggressiveness. The degree of cognitive impairment may range from subtle derangements in attention, reason, clarity of thought and capacity of decision making to confusion and delirium. Sleep deprivation can also induce hypertension, fatigue, metabolic disorders, cerebrovascular and cardiovascular disease

02

Conditions studied

  • Sleep
  • Atrial Fibrillation
  • Delirium, Postoperative
  • Complications, Postoperative

Keywords

  • Cardiac surgery
  • Sleep quality
03

In context

Atrial Fibrillation

3,957 studies on the registry are indexed under Atrial Fibrillation; 933 are open to participants now.

This study's planned enrollment of 100 is below the median of 145 across 2,437 interventional studies indexed under Atrial Fibrillation.

Browse Atrial Fibrillation studies →

Lead sponsor

Amrita Institute of Medical Sciences & Research Center is the lead sponsor of 4 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adult cardiac surgical patients aged above 18years undergoing elective cardiac surgery

Exclusion criteria

Exclusion Criteria:

  • Not willing to give consent
  • Preoperative sleep medications use
  • Preoperative psychological disorders, on mechanical ventilation for >12hrs, dementia, cerebrovascular accident
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
100 participants (estimated)

Study arms

  • Active comparator
    Interventional group

    Eye masks and Ear plugs given during sleep

    Device: Eye masks and ear plugs

  • No intervention
    Control group

    Routine care given without any intervention

Interventions

  • DeviceEye masks and ear plugs

    Eye masks and ear plugs given during sleeping time in Icu After cardiac surgery

06

What researchers measure

Primary outcomes

  1. Quality of sleep

    On the morning after the intervention, patient's sleep quality will be assessed using Richard-Campbell sleep questionnaire (RCSQ). Each point in RCSQ will be scored using a visual analog score, ranging from 0-100. Total score will be calculated and then will be divided by 5.

    Time frame: 6 months

Secondary outcomes

  1. Atrial fibrillation

    Postoperative atrial fibrillation

    Time frame: 6 months

  2. Delirium

    Postoperative Delirium

    Time frame: 6 months

  3. Intensive care unit stay

    Duration of intensive care unit stay (in hours to days)

    Time frame: 6 months

  4. Vasoactive inotropic score

    Vasoactive inotropic score is calculated by multiplying the dose of each vasoactive drug used with 10. (minimum score is 0, while maximum score can go upto 20. Higher the score worse is the outcome

    Time frame: 6 months

  5. Mechanical ventilation

    Duration of mechanical ventilation (hours)

    Time frame: 6 months

07

Study locations

1 of 1 sites recruiting
  • Dr. Nagarjuna
    Kochi, Kerala 682041, India
    • Nagarjuna P, MD, DM · Contact
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jul 2024 (actual). Primary completion is estimated for Dec 2024, 5 months after the start.

Of 789 non-industry interventional studies with no phase under Atrial Fibrillation, half reached primary completion within 39 months of starting (the median), counting those still running; a quarter within 21 and three quarters within 59. This study's planned 5 months is below that.

Counting every sponsor, half of 1,031 studies reached it within 34 months; a quarter within 18 and three quarters within 54.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 23, 2024
First posted
Jul 30, 2024
StartActual
Jul 22, 2024
Primary completionEst.
Dec 31, 2024
CompletionEst.
Jan 31, 2025
Last update
Sep 25, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 25, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06527105
Lead sponsor
Amrita Institute of Medical Sciences & Research Center
Responsible party
Nagarjuna P (Assistant Professor, Department of Cardiac Anesthesia, Amrita Institute of Medical Sciences & Research Center) — Principal investigator
First posted
Jul 30, 2024
Start date
Jul 22, 2024
Primary completion
Dec 31, 2024 (estimated)
Completion
Jan 31, 2025 (estimated)
Last update
Sep 25, 2024

Study contacts

Nagarjuna P, MD, DM
Contact
drarjun83@gmail.com
9177208286 ext. 091
Nagarjuna P
Contact
7981144584

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Sep 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion